Authors
Loading...
Laboratory evaluation reveals IgM granulocytotoxic antibodies in levamisole-treated neutropenic patients, suggesting prospective antibody screening can identify high-risk individuals.
Thompson et al. (1980) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: